CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

By Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, S. Dagogo-Jack, Ralph A. DeFronzo, Daniel Einhorn, Vivian A Fonseca and 11 more. Endocrine Practice, 2016

599 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pharmacology

View Paper: https://www.semanticscholar.org/paper/c2b5d690e5db70cf266c9cd9ef6ff5dd20304a3b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. L. Adams
2. Z. Younossi

Citations in the corpus

• International Consensus on Use of Continuous Glucose Monitoring (2017, methodology): “• Self-monitoring of blood glucose (SMBG) has been shown to be helpful or to correlate with effective management in insulin-treated and non-insulin-treated diabetes (1-4, 21, 22) [C,C,C,C,A,C], however, SMBG has notable limitations.”
• The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease (2020, background): “5% is considered optimal if it can be achieved in a safe and cost-effective manner [110].”
• Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management (2017, background): “Several options for pharmacologic therapy of lowering blood glucose are currently available, which have revolutionized longterm management of DM (47).”